Chloe completed her B.A. Natural Science (Moderatorship in Immunology) in 2018 and PhD in immunometabolism in 2023 at Trinity College Dublin, Ireland. Her research focused on Natural Killer cell immunometabolism and illustrated the importance of nutrient availability in regulating proper activation of immune cells. She is enthusiastic about translational and clinical research.
Chloe joined NCARD in 2025 as a Research Associate and her research focuses on identifying antigen targeted therapy against childhood cancers (KIDS-ATTAC), in particular paediatric leukaemia and brain cancer.